title: OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trial.
authors.affiliation: Fourth Department of Surgery, Helsinki University, Finland.
authors.forename: K
authors.initials: K
authors.lastname: Höckerstedt
authors.forename: B G
authors.initials: BG
authors.lastname: Ericzon
authors.forename: H
authors.initials: H
authors.lastname: Bismuth
authors.forename: Y
authors.initials: Y
authors.lastname: Chapuis
authors.forename: O
authors.initials: O
authors.lastname: Farges
authors.forename: J L
authors.initials: JL
authors.lastname: Faure
authors.forename: D
authors.initials: D
authors.lastname: Galmarini
authors.forename: D
authors.initials: D
authors.lastname: Houssin
authors.forename: S V
authors.initials: SV
authors.lastname: Lynch
authors.forename: J
authors.initials: J
authors.lastname: Miguet
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011446:Prospective Studies; D013256:Steroids / Q000627:therapeutic use; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine